CIML NK Cells With Venetoclax for AML

NCT06152809 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Acute Myeloid Leukemia Recurrent
Leukemia
Leukemia, Myeloid

Interventions

BIOLOGICAL: Cytokine-Induced Memory-like Natural Killer Cells
BIOLOGICAL: Interleukin-2
DRUG: Venetoclax

Sponsor

Dana-Farber Cancer Institute